Learn More
AIM To compare survival on different beta-blockers in heart failure. METHODS AND RESULTS We identified all Danish patients ≥35 years of age who were hospitalized with a first admission for heart(More)
AIMS Metformin is the first-line treatment for most patients with type 2 diabetes but many patients need additional treatment with insulin secretagogues (IS) to achieve glycemic control. We aimed to(More)
AIM Dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) agonists are widely used in combinations with metformin in the treatment of type 2 diabetes; however, data on(More)
AIM We performed a retrospective cohort study, investigating the clinical outcomes including mortality and cardiovascular disease of sitagliptin compared with metformin monotherapies. METHODS All(More)
  • 1